Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Medical Cyclotron Market Size, Share & Trends Analysis Report by Product (10-12 MeV, 16-18 MeV, 19-24 MeV, 24 MeV & Above), Region (North America, Europe, Asia Pacific, Latin America, MEA), and Segment Forecasts, 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The global medical cyclotron market size is expected to reach USD 477.9 million by 2030, according to the report., registering a CAGR of 11.0% during the forecast period. Increasing prevalence of cancer and surging demand for nuclear scans for accurate diagnosis are among the key factors stimulating the growth of the market. Apart from this, cost advantage over outsourced radioactive tracers and availability of technologically advanced diagnostic devices such as PET and SPECT are playing a pivotal role to escalate market growth. 
Cancer is becoming the global pandemic as it causes one in eight deaths worldwide. According to the International Agency for Research on Cancer (IARC), in 2012, there were about 14.1 million new cancer cases and 8.2 million deaths due to cancer. With continuous increase in the incidence of chronic diseases, the number of new cancer cases is anticipated to reach 21.7 million and result in 13 million deaths by 2030. Due to mounting cases of cancer, the need for accurate diagnostics is increasing, which is estimated to fuel the demand for medical cyclotrons.
Nuclear scans for diagnosis use a smaller amount of radioactive material. Nuclear tracers help to find the exact location of growing tumors. Technetium-99m (Tc-99m), strontium, thallium, gallium, and radioactive iodine are some of the radioactive materials used in diagnosis and treatment of tumor. Increase in acceptability of particle accelerators for manufacturing tracer material is projected to trigger the growth of the market over the forecast period.
Medical Cyclotron Market Report Highlights
- Asia Pacific held the leading share of about 50% in 2022, due to spiraling demand for nuclear scans, rising cancer prevalence, and increasing demand for cost-effective diagnosis.
- Middle East & Africa is expected to grow at the fastest CAGR of 16.7% during the forecast period.
- The cyclotron 19-24 MeV segment is expected to grow at the fastest CAGR of 12.1 % over the forecast period of 2023-2030.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 99 |
| Forecast Period | 2022-2030 |
| Estimated Market Value (USD) in 2022 | $209.7 Million |
| Forecasted Market Value (USD) by 2030 | $477.9 Million |
| Compound Annual Growth Rate | 11.0% |
| Regions Covered | Global |
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Medical Cyclotron Market, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Medical Cyclotron Market Analysis Tools
3.4.1. Industry analysis - Porter's
3.4.2. PESTEL analysis
Chapter 4. Medical Cyclotron Market: Product Estimates & Trend Analysis
4.1. Medical Cyclotron Market: Key Takeaways
4.2. Medical Cyclotron Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Cyclotron 10-12MeV
4.3.1. Cyclotron 10-12MeV market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Cyclotron 16-18MeV
4.4.1. Cyclotron 16-18MeV market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cyclotron 19-24MeV
4.5.1. Cyclotron 19-24MeV market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Cyclotron above 24MeV
4.6.1. Cyclotron above 24MeV market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Medical Cyclotron Market: Regional Estimates & Trend Analysis
5.1. Regional Outlook
5.2. Medical Cyclotron Market by Region: Key Marketplace Takeaway
5.3. North America
5.3.1. U.S.
5.3.2. Canada
5.4. Europe
5.4.1. UK
5.4.2. Germany
5.4.3. France
5.4.4. Italy
5.4.5. Spain
5.4.6. Sweden
5.4.7. Norway
5.4.8. Denmark
5.5. Asia Pacific
5.5.1. Japan
5.5.2. China
5.5.3. India
5.5.4. Australia
5.5.5. Thailand
5.5.6. South Korea
5.6. Latin America
5.6.1. Brazil
5.6.2. Mexico
5.6.3. Argentina
5.7. MEA
5.7.1. Saudi Arabia
5.7.2. South Africa
5.7.3. UAE
5.7.4. Kuwait
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.2.1. Siemens Medical Solutions USA, Inc.
6.2.2. IBA Radiopharma Solutions
6.2.3. GE HealthCare
6.2.4. Advanced Cyclotron Systems, Inc.
6.2.5. TeamBest
6.2.6. Sumitomo Heavy Industries, Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/aob6p9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
